Intellia Therapeutics, Inc. (NTLA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.81 | +27.4% |
| 2024 | $-5.25 | +3.1% |
| 2023 | $-5.42 | +12.0% |
| 2022 | $-6.16 | -63.0% |
| 2021 | $-3.78 | -57.5% |
| 2020 | $-2.40 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.81 | +27.4% |
| 2024 | $-5.25 | +3.1% |
| 2023 | $-5.42 | +12.0% |
| 2022 | $-6.16 | -63.0% |
| 2021 | $-3.78 | -57.5% |
| 2020 | $-2.40 | — |